Managing paediatric Graves’ disease

Rashmi Aggarwal, Pradeep Chugh, Mitra Basu

Abstract


Graves’ disease is the most common cause of hyperthyroidism in children. Anti-thyroid drug treatment with carbimazole or its active metabolite methimazole is offered as first line initial treatment but it induces remission in only 30%of children. Propylthiouracil is not recommended in children because of its association with severe hepatic toxicity. For those who relapse after ATD, radioactive iodine can be offered as definitive therapy except in cases with severe Graves’ ophthalmopathy or patients with large goitre who are the candidates for surgery. Total (or near total) thyroidectomy  is the surgical procedure of choice for treating paediatric patients with  Graves’ disease as it reduces the risk of recurrent hyperthyroidism which was seen in patients undergoing subtotal or partial thyroidectomy.


Keywords


Hyperthyroidism, Anti-thyroid drugs, Radioactive iodine, Thyroidectomy

Full Text:

PDF

References


Rivkees SA. Pediatric Graves’ disease: controversies in management. Horm Res Paediatr. 2010;74:305-11.

Bauer AJ. Approach to the pediatric patientwith Graves’ disease: when is definitive therapy warranted. Clin Endocrinol Metab. 2011;96(3):580-8.

LovardL, Ranlov L, Perrild H, Anderson O, Jacobsen BB. Incidence of juvenile thyrotoxicosis in Denmark 1982-1988. A Nationwide study. Eur J Endocrinol. 1994;130:565-8.

Mizokami T, Yamauchi A, Sato Y, Toyonaga M, Imoto H, Kojima H, Saji H, Nunoi K. Simultaneous occurrence of type 1 diabetes mellitus and Graves’ disease: a report of two cases and review of literature. Intern Med. 2013;52(22):2537-43.

BrixTH, Kyvik KO, Hegedus L. What is the evidence of genetic factors in the etiology of Graves’ disease: a brief review. Thyroid. 1998;8:729-34.

BrixTH, Kyvik KO, Hegedus L, Christensen K. Evidence for a major role of heredity in Graves’ disease: a population based study of two Danish twin cohorts. J Clin Endocrinol Metab. 2001;86:930-4.

Niedziela M, Korman E. Thyroid carcinoma in a fourteen year boy with Graves’ disease. Med Pediatr Oncol. 2002;38;325-9.

Cooper DS. Anti-thyroid drugs. N Engl J Med. 2005;352:905-17.

Kaguelidou F, Alberti C, Castanet M, Guittany M A, Czernichow P, Leger J. Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of anti-thyroid drug treatment. J Clin Endocrinol Metab. 2008;93:3817-26.

Cooper DS. Anti-thyroid drugs in the management of patients with Graves’ disease: an evidence based approach to therapeutic controversies. J Clin Endocrinol Metab. 2003;88:3474-81.

Ohye H, Minagawa A, Noh JY, Mukasa K, Kunii Y, Watanabe N. Anti-thyroid drug treatment for Graves’ disease in children: a long term retrospective study at a single institution. Thyroid. 2014 Feb;24(2):200-7.

Leger J, Gelwane G, Kaguelidou F, Benmerad M, Alberti C. Positive impact of long term anti-thyroid drug treatment on the outcome of children with Graves’ disease: national long term cohort study. J Clin Endocrinol Metab. 2012;97:110-9.

Wartofsky L. Radio iodine therapy for Graves’ disease: case selection and restrictions recommended to patients in North America. Thyroid 1997;7(2);213-6.

Allahahadia A, Daykin J, Holder RL, Sheppard MC, Gough SC, Franklyn JA. Age and gender predict the outcome of treatment for Graves’ hyperthyroidism. J Clin Endocrinol Metab. 2000;85:1038-42.

Leger J, Carel JC. Hyperthyroidism in childhood: causes, when and how to treat. J Clin Res Pediatr Endocrinol. 2013;5(Suppl 1):50-6.

Read JR, Tansey MJ, Menday Y. A 36 year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves’ disease patients. J Clin Endocrinol Metab. 2004;89:4229-33.

Kadmon PM, Noto RB, Bone CM, Goodwin G, Gruppuso PA. Thyroid storm in a child following radioactive iodine therapy: a consequence of RAI versus withdrawal of anti-thyroid medication. J Clin Endocrinol Metab. 2001;86:1865-7.

Lee JA, Grumbach MM, Clark OH. The optimal treatment of paediatric Graves’ disease is surgery. J Clin Endocrinol Metab. 2007;92:801-3.

Jukic T, Slancic J, Petri CV, Kusic Z. Radioactive iodine versus surgery in the treatment of Graves’ hyperthyroidism. Lijec Viesn. 2010;132:355-60.

Rivkess SA, Mattison DR. Ending propyl thiouracil-induced liver failure in children. N Engl J Med. 2009;360:1584-7.

Rivkess SA. 63 years and 715 days to the boxed warning: unmasking of the propyl thiouracil problem. Int J Pediatr Endocrinol. 2010;2010:PMC2913555.